Form 4: iRhythm CFO Sells Shares for Tax Obligations
Statement of Changes in Beneficial Ownership
iRhythm Technologies' CFO, Daniel G. Wilson, sold 737 shares of common stock to cover tax obligations related to RSU vesting.
Summary
- Daniel G. Wilson, Chief Financial Officer of iRhythm Technologies, Inc. (IRTC), reported a transaction on September 2, 2025.
- Mr. Wilson sold 737 shares of iRhythm Technologies Common Stock at a price of $167.28 per share.
- The sale was executed to cover tax withholding and remittance obligations associated with the vesting of Restricted Stock Units (RSUs).
- Following this transaction, Mr. Wilson directly beneficially owns 39,470 shares of Common Stock.
- Additionally, Mr. Wilson indirectly beneficially owns 100 shares of Common Stock through The Wilson Living Trust dated July 9, 2015, for which he is the Trustee.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a non-discretionary sale of shares to cover tax obligations related to RSU vesting, which is a routine event and not indicative of management's sentiment towards the company's future prospects.
Positives
- The transaction represents a routine event related to executive compensation, specifically the vesting of Restricted Stock Units (RSUs), indicating the executive is receiving compensation as part of their employment agreement.
Negatives
- The sale of shares, even for tax purposes, results in a slight reduction of direct insider ownership, though it is not indicative of a lack of confidence in the company's future given the stated reason.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing is a standard insider transaction report and does not provide information directly related to broader industry trends or competitive landscape. It reflects a routine compensation event for an executive within the medical technology sector.
Related Party Transactions
- Mr. Wilson holds 100 shares indirectly through The Wilson Living Trust dated July 9, 2015, of which he is the Trustee.
Stakeholder Impact
- Shareholders: The impact on shareholders is minimal as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in company fundamentals or management's confidence.
- Employees: The transaction is a result of executive compensation, which is a standard practice within the company's compensation structure.
Key Dates
| Date | Description |
|---|---|
| 09/02/2025 | Date of transaction (sale of common stock). |
| 09/03/2025 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
iRhythm Technologies, IRTC, Form 4, Insider Transaction, Stock Sale, RSU Vesting, Tax Withholding, Daniel G. Wilson, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.